CCL5 and ovarian cancer: Furthermore, ovarian cancer cells have been shown to reprogram normal fibroblasts into becoming CAFs through the downregulation of miR-214, which increased the production of CCL5 and endowed fibroblasts with tumor-promoting properties (32).